Population Incidence of Guillain-Barre Syndrome: A Systematic Review and Meta-Analysis

被引:615
作者
Sejvar, James J.
Baughman, Andrew L.
Wise, Matthew
Morgan, Oliver W.
机构
[1] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA USA
[2] Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Atlanta, GA USA
关键词
Guillain-Barre syndrome; incidence; meta-analysis; PUBLIC-HEALTH SURVEILLANCE; IMMUNIZATION; SPAIN; EPIDEMIOLOGY; VACCINATION; FEATURES; DISEASE; SAFETY;
D O I
10.1159/000324710
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Population incidence of Guillain-Barre syndrome (GBS) is required to assess changes in GBS epidemiology, but published estimates of (GBS incidence vary greatly depending on case ascertainmem, definitions, and sample size. We performed a meta-analysis of articles on GBS incidence by searching Medline (1966-2009), Embase (1988-2009), Cinahl (1981-2009) and CABI (1973-2009) as well as article bibliographies. We included studies from North America and Europe with at least 20 cases, and used population-based data, subject matter experts to confirm GBS diagnosis, and an accepted GBS case definition. With these data, we fitted a random-effects negative binomial regression model to estimate age-specific GBS incidence. Of 1,683 nonduplicate citations, 16 met the inclusion criteria, which produced 1,643 cases and 152.7 million person-years of follow-up. GBS incidence increased by 20% for every 10-year increase in age; the risk of GBS was higher for males than females. The regression equation for calculating the average GBS rate per 100,000 person-years as a function of age in years was exp[-12.0771 + 0.01813(age in years)] x 100,000. Our findings provide a robust estimate of background GBS incidence in Western countries. Our regression model may be used in comparable populations to estimate the background age-specific rate of GBS incidence for future studies. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:123 / 133
页数:11
相关论文
共 38 条
[1]  
Aladro-Benito Y, 2002, REV NEUROLOGIA, V35, P705
[2]  
[Anonymous], 1978, Ann Neurol, V3, P565
[3]   ASSESSMENT OF CURRENT DIAGNOSTIC-CRITERIA FOR GUILLAIN-BARRE-SYNDROME [J].
ASBURY, AK ;
CORNBLATH, DR .
ANNALS OF NEUROLOGY, 1990, 27 :S21-S24
[4]  
BAGOS P, INT J BIOSTAT
[5]   The Guillain-Barre syndrome (GBS) - Implementation of a register of the disease on a nationwide basis [J].
Beghi, E ;
Bogliun, G .
ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1996, 17 (05) :355-361
[6]  
BEGHI E, 1985, ARCH NEUROL-CHICAGO, V42, P1053, DOI 10.1001/archneur.1985.04060100035016
[7]   Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines [J].
Black, Steven ;
Eskola, Juhani ;
Siegrist, Claire-Anne ;
Halsey, Neal ;
MacDonald, Noni ;
Law, Barbara ;
Miller, Elizabeth ;
Andrews, Nick ;
Stowe, Julia ;
Salmon, Daniel ;
Vannice, Kirsten ;
Izurieta, Hector S. ;
Akhtar, Aysha ;
Gold, Mike ;
Oselka, Gabriel ;
Zuber, Patrick ;
Pfeifer, Dina ;
Vellozzi, Claudia .
LANCET, 2009, 374 (9707) :2115-2122
[8]   Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996 [J].
Bogliun, G ;
Beghi, E .
ACTA NEUROLOGICA SCANDINAVICA, 2004, 110 (02) :100-106
[9]   Validity-of hospital discharge diagnoses for public health surveillance of the Guillain-Barre syndrome [J].
Bogliun, G ;
Beghi, E .
NEUROLOGICAL SCIENCES, 2002, 23 (03) :113-117
[10]  
Casmiro M, 1998, J NEUROL NEUROSUR PS, V65, P218